With Experience and Excellence.

We take your projects to the next level with our personal commitment for your commercial success.

Our Company History Location Leadership Board of Directors Our Approach News Releases

Services & Capabilities

Personally Comitted to Your Success.

Avid Bioservices offers our clients full lifecycle capabilities—from Concept to Commercial Supply. We pride ourselves on the personal commitment our team offers, ensuring your project success, at every step of the way.

Mammalian Protein Development & Manufacturing Services Viral Vector Development & Manufacturing Services

State-of-the-art Infrastructure and Operational Excellence.

Located in Orange County, California, our CGMP facilities are dedicated to mammalian cell culture with production for both clinical and commercial biologics. We provide our clients flexibility by offering stainless steel and single-use options.

Our Facilities Expansion

With Presence and Expertise.

Our business operations team and technical experts are excited to meet you at industry conferences and events.

Upcoming Corporate Events Conferences Webinars Technical Seminars Archived Events Investor Events

Knowledgeable and Leading the Way.

Our technical team members continue to lead the industry, one process at a time; while expertly providing and sharing resources with our colleagues and industry peers.

Thought Leadership Archived Webinars Case Studies Presentations Articles Fact Sheets Videos Industry Links

Investor Relations

Overview Corporate Presentation Investor Events News Releases SEC Filings Corporate Governance Stock Quote & Chart Analyst Coverage Investor FAQs Email Alerts Contact Us

Thought Leadership

All

Article

A Viral Vector CDMO Vision that Resonates

Building a viral vector manufacturing facility from the ground up. Members of Avid Bio's leadership team discuss the key considerations that went into designing their viral vector manufacturing facility and how it will deliver quality viral vector process development and CGMP manufacturing.

Cell and Gene Therapy Insights: Can AAV continue to deliver the promise of gene therapy?

Charlotte Barker (Editor, BioInsights) speaks to Elie Hanania, PhD (Vice President of Process Development Viral Vector Technologies, Avid Bioservices) about the current status and future manufacturing of AAV-based gene therapies, including how to streamline large-scale manufacturing.

Approaching Viral Vector Manufacturing With An Emphasis On Quality & Design

Adapting an existing facility for viral vector manufacturing purposes presents challenges that have the potential to impact safety and integrity. A dedicated facility, built from the ground up, enables CDMOs to address areas of concern specific to viral vectors. Learn more about how Avid’s purpose-built approach is answering the industry need for quality viral vector manufacturing.

A Customer-Centric Approach to Cell & Gene Therapy Manufacturing

Learn more about the drivers motivating Avid Bio’s entrance into the viral vector space, and the unique and differentiating value the company can offer cell and gene therapy developers.

Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.

Jeanette Doerr, Ph.D. & Haiou Yang, Ph.D.

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

Expanding and Serving the Market with Flexible Single-Use Capacity

Michael Alston, Jr.

Strong Quality Systems and Quality Culture Ensure Inspection-Ready Status

Unique Commercial Experience Primes Avid Bioservices for Growth

Successful Biosimilar Development Requires an Outsourcing Partner with the Right Experience

Richard Richieri